Hany Massarany, President and CEO at GenMark Diagnostics, Inc. (GNMK), sold 20,738 shares at $6.60 ($137K) on 2019-05-30, disclosed to the SEC on 2019-05-31.
Seasonal sale ($137k) by President and CEO — this insider has traded GNMK in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.60 | 10,369 | $68K | 50.0% |
| 2 | $6.60 | 10,369 | $68K | 50.0% |
| Total | $6.60 avg | 20,738 | $137K | 100% |
| Filing → |
| AXDX | BUY | 2022-02-01 | $66K | — | Filing → |
| AXDX | BUY | 2021-09-28 | $53K | — | Filing → |
| BDSX | BUY | 2020-11-03 | $135K | — | Filing → |